ATE30729T1 - Somatostatin-derivate, verfahren zu ihrer herstellung, die sie enthaltenden veterinaeren zusammensetzungen und verfahren zur behandlung von tieren. - Google Patents

Somatostatin-derivate, verfahren zu ihrer herstellung, die sie enthaltenden veterinaeren zusammensetzungen und verfahren zur behandlung von tieren.

Info

Publication number
ATE30729T1
ATE30729T1 AT85870041T AT85870041T ATE30729T1 AT E30729 T1 ATE30729 T1 AT E30729T1 AT 85870041 T AT85870041 T AT 85870041T AT 85870041 T AT85870041 T AT 85870041T AT E30729 T1 ATE30729 T1 AT E30729T1
Authority
AT
Austria
Prior art keywords
animals
manufacture
processes
treatment
methods
Prior art date
Application number
AT85870041T
Other languages
English (en)
Inventor
Georges Paul Guillaume Hennen
Jean Lambert Rene Closset
Quang Mihn Dit Sato Tran
Original Assignee
Techland Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19730232&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE30729(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Techland Sa filed Critical Techland Sa
Application granted granted Critical
Publication of ATE30729T1 publication Critical patent/ATE30729T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6062—Muramyl peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Feed For Specific Animals (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT85870041T 1984-03-26 1985-03-20 Somatostatin-derivate, verfahren zu ihrer herstellung, die sie enthaltenden veterinaeren zusammensetzungen und verfahren zur behandlung von tieren. ATE30729T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU85269A LU85269A1 (fr) 1984-03-26 1984-03-26 Composes nouveaux de somatostatine,procede pour leur synthese,preparation a usage veterinaire contenant lesdits composes et procede pour le traitement d'animaux
EP85870041A EP0157753B1 (de) 1984-03-26 1985-03-20 Somatostatin-Derivate, Verfahren zu ihrer Herstellung, die sie enthaltenden veterinären Zusammensetzungen und Verfahren zur Behandlung von Tieren

Publications (1)

Publication Number Publication Date
ATE30729T1 true ATE30729T1 (de) 1987-11-15

Family

ID=19730232

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85870041T ATE30729T1 (de) 1984-03-26 1985-03-20 Somatostatin-derivate, verfahren zu ihrer herstellung, die sie enthaltenden veterinaeren zusammensetzungen und verfahren zur behandlung von tieren.

Country Status (14)

Country Link
EP (1) EP0157753B1 (de)
JP (1) JPS60222499A (de)
KR (1) KR850006942A (de)
AT (1) ATE30729T1 (de)
AU (1) AU4037485A (de)
DE (1) DE3560949D1 (de)
DK (1) DK133085A (de)
ES (1) ES8605147A1 (de)
GR (1) GR850746B (de)
IL (1) IL74701A0 (de)
LU (1) LU85269A1 (de)
NO (1) NO851084L (de)
PT (1) PT80159B (de)
ZA (1) ZA852224B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599229A (en) * 1985-09-09 1986-07-08 International Minerals & Chemical Corp. Method of promoting animal growth using antibodies against somatostatin
HU206890B (en) * 1986-10-13 1993-01-28 Sandoz Ag Process for producing sugar-modified somatostatin peptide derivatives and pharmaceutical compositions containing them as active components
CH679045A5 (de) * 1987-06-29 1991-12-13 Sandoz Ag
FR2622455B1 (fr) * 1987-11-04 1991-07-12 Agronomique Inst Nat Rech Application du facteur de stimulation de la secretion de l'hormone de croissance humaine, de ses fragments actifs et des analogues correspondants, pour augmenter la production laitiere et le poids des nouveau-nes chez les mammiferes
US5552534A (en) * 1991-08-22 1996-09-03 The Trustees Of The University Of Pennsylvania Non-Peptide peptidomimetics
AU3361093A (en) * 1992-01-20 1993-08-03 Peptech (Uk) Limited Use of muramyl peptides for enhancing animal production
IT1283134B1 (it) * 1996-07-08 1998-04-07 Dox Al Italia Spa Derivati sintetici e semisintetici di somatostatine utili nella stimolazione della crescita corporea, in particolare in
US7229793B1 (en) 1999-11-19 2007-06-12 Shire Human Genetic Therapies, Inc. Constructs and cells for production of small peptides
FR2852247A1 (fr) * 2003-03-11 2004-09-17 Centre Nat Rech Scient Utilisation de ligands peptidiques de recepteurs de la membrane plasmique et de leurs analogues pour moduler l'activite des mitochondries
BR112014004784A2 (pt) * 2011-09-04 2017-03-21 Glytech Inc polipeptídeo glicosilado e composição de drogas contendo referido polipeptídeo
RU2627184C2 (ru) * 2011-09-04 2017-08-03 Глитек, Инк. Гликозилированные полипептиды и лекарственные композиции, содержащие данные полипептиды

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2522967B1 (fr) * 1982-03-15 1986-03-07 Anvar Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant

Also Published As

Publication number Publication date
ES541532A0 (es) 1986-04-01
EP0157753B1 (de) 1987-11-11
NO851084L (no) 1985-09-27
JPS60222499A (ja) 1985-11-07
KR850006942A (ko) 1985-10-25
PT80159B (en) 1986-11-10
AU4037485A (en) 1985-10-03
LU85269A1 (fr) 1985-10-14
ES8605147A1 (es) 1986-04-01
EP0157753A1 (de) 1985-10-09
ZA852224B (en) 1985-11-27
DK133085A (da) 1985-09-27
PT80159A (en) 1985-04-01
DE3560949D1 (en) 1987-12-17
IL74701A0 (en) 1985-06-30
GR850746B (de) 1986-05-13
DK133085D0 (da) 1985-03-25

Similar Documents

Publication Publication Date Title
DE3771367D1 (de) Verfahren zur pflanzenzucht und behaelter dafuer.
DE3668782D1 (de) Kuenstliche lunge des membrantyps und verfahren zu ihrer herstellung.
DE69005711D1 (de) Verfahren zur Herstellung von P-Typ-II-VI-Halbleitern.
ATE30729T1 (de) Somatostatin-derivate, verfahren zu ihrer herstellung, die sie enthaltenden veterinaeren zusammensetzungen und verfahren zur behandlung von tieren.
DE3788399D1 (de) Verfahren zur Herstellung von eingekapseltem Toner.
DE3677349D1 (de) Kuenstliche lunge des membrantyps und verfahren zu ihrer herstellung.
DE3780527D1 (de) Verfahren zur herstellung von 5'-guanyl-saeure.
DE3776173D1 (de) Verfahren zur herstellung von saeureamiden.
DE3482261D1 (de) Ein-topfverfahren fuer herstellung von 7 beta-amino- und 7 beta-acylamino-3-substituierte methyl-3-cephem-4-carboxylsaeure-verbindungen und verfahren zur deoxygenation von 7 beta-acylamino-3-cephem-4-carboxylsaeure-1-oxyd-verbindungen.
DE3578862D1 (de) Verfahren zur herstellung von 5,6,7,8-tetrahydrofolsaeure.
DE3482469D1 (de) N-acyl-anthranilsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses.
DE3586741D1 (de) Verfahren zur herstellung von 5'-guanylsaeure.
DE3674027D1 (de) Methode zur herstellung von phenylbrenztraubensaeure.
ATE84666T1 (de) Sichere pestizide harzzusammensetzungen zur bekaempfung von bodenbuertigen krankheiten und verfahren zu deren herstellung.
DE3886786D1 (de) Verfahren zur Herstellung von Cimetidin.
DE3381704D1 (de) 1,2,4,6-thiatriazin-1,1-dioxid-ether, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses.
DE3771098D1 (de) Wasserabsorbierende, fasergebende zusammensetzung, diese enthaltende gegenstaende und verfahren zur herstellung dieser zusammensetzung und dieses gegenstands.
DE3862402D1 (de) Verfahren zur herstellung von 2,3,5,6-tetrafluorbenzoesaeure.
ATE57912T1 (de) Verfahren zur herstellung von anilinofumarat und 2,3-chinolindicarbonsaeure.
DE3685122D1 (de) Verfahren zur herstellung von 1,4-diaminoanthrachinon-2-sulfonsaeure.
ATE29489T1 (de) 2-azetidinylessigsaeure,ihre herstellung,sie enthaltende zusammensetzungen und verfahren zur sterilisierung von pflanzenstaubbeuteln.
DE3577555D1 (de) Verfahren zur herstellung von thiazolglutaconsaeure-derivaten.
ATA122593A (de) Verfahren zur herstellung von 2,4-dioximidazolidin-5-phosphonsäuredialkyleste n
ATE36335T1 (de) Verfahren zur herstellung von milchsaeuresilylestern.
AT379171B (de) Verfahren zur mikrobiologischen herstellung von nebramycin-5'

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties